08/01/2025 4:24 PM | Portage Biotech (Filer)
| Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
07/28/2025 8:00 AM | Portage Biotech (Filer)
| Form 424B3 | |
07/25/2025 3:20 PM | Portage Biotech (Filer)
| Form 20-F Registration statement / Annual report / Transition report | |
07/25/2025 3:25 PM | Portage Biotech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/25/2025 3:31 PM | Portage Biotech (Filer)
| Form 424B3 | |
06/27/2025 3:25 PM | Portage Biotech (Filer)
| Form 424B3 | |
06/25/2025 6:26 AM | Portage Biotech (Filer)
| Form 424B3 | |
06/25/2025 6:15 AM | Portage Biotech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/09/2025 6:00 AM | Portage Biotech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/09/2025 6:14 AM | Portage Biotech (Filer)
| Form 424B3 | |
05/29/2025 3:30 PM | Portage Biotech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
Get the Latest News and Ratings for PRTG and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Portage Biotech and its competitors with MarketBeat's FREE daily newsletter.
|
05/14/2025 11:15 PM | Portage Biotech (Filer)
| Form EFFECT | |
04/28/2025 5:20 AM | Portage Biotech (Filer)
| Form 424B3 | |
04/28/2025 5:10 AM | Portage Biotech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/27/2025 3:37 PM | Portage Biotech (Filer)
| Form 424B3 | |
03/13/2025 3:34 PM | Portage Biotech (Filer)
| Form 424B3 | |
03/12/2025 7:20 AM | Portage Biotech (Filer)
| Form 424B3 | |
03/12/2025 7:10 AM | Portage Biotech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/12/2025 3:25 PM | Portage Biotech (Filer)
| Form 424B3 | |
02/12/2025 3:20 PM | Portage Biotech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/06/2025 5:00 AM | Portage Biotech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/06/2025 5:12 AM | Portage Biotech (Filer)
| Form 424B3 | |
12/19/2024 3:43 PM | Mellon James (Filed by) Portage Biotech (Subject)
| Form SCHEDULE 13D/A | |
12/17/2024 6:05 AM | Portage Biotech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/17/2024 6:11 AM | Portage Biotech (Filer)
| Form 424B3 | |
12/13/2024 3:35 PM | Portage Biotech (Filer)
| Form 424B3 | |
12/13/2024 3:15 PM | Portage Biotech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/12/2024 4:01 PM | Portage Biotech (Filer)
| Form 424B3 | |
12/12/2024 3:30 PM | Portage Biotech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/05/2024 3:35 PM | Portage Biotech (Filer)
| Form 424B3 | |
12/05/2024 3:28 PM | Portage Biotech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/26/2024 3:47 PM | Portage Biotech (Filer)
| Form 424B3 | |
11/26/2024 3:25 PM | Portage Biotech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/14/2024 3:26 PM | ARMISTICE CAPITAL, LLC (Filed by) Portage Biotech (Subject)
| Form SC 13G/A | |
10/04/2024 3:30 PM | Portage Biotech (Filer)
| Form 424B3 | |
10/04/2024 3:15 PM | Portage Biotech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/03/2024 8:18 PM | Portage Biotech (Subject) Shaw Allan (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/27/2024 3:28 PM | Portage Biotech (Subject) Shaw Allan (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/23/2024 8:41 AM | MINTZ STEVEN (Reporting) Portage Biotech (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/20/2024 10:25 AM | Bailey Gregory (Reporting) Portage Biotech (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/27/2024 11:15 PM | Portage Biotech (Filer)
| Form EFFECT | |
$100 Trillion “AI Metal” Found in American Ghost Town (Ad) Jeff Brown recently traveled to a ghost town in the middle of an American desert…
To investigate what could be the biggest technology story of this decade.
In short, he believes what he's holding in his hand is the key to the $100 trillion AI boom…
And only one company here in the U.S. can mine this obscure metal. Click here to get the details on this virtual monopoly. |
08/27/2024 7:30 AM | Portage Biotech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/27/2024 5:05 AM | Portage Biotech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/27/2024 5:11 AM | Portage Biotech (Filer)
| Form 424B3 | |
08/15/2024 7:31 AM | Portage Biotech (Filer)
| Form 424B3 | |
08/15/2024 7:00 AM | Portage Biotech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/14/2024 4:29 PM | Portage Biotech (Filer)
| Form 20-F Registration statement / Annual report / Transition report | |
08/13/2024 7:52 AM | Portage Biotech (Filer)
| Form 424B3 | |
08/13/2024 7:00 AM | Portage Biotech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |